News

Filter

Current filters:

None

Popular Filters

7878 to 7902 of 8831 results

Dendreon cashes in Victrelis royalty

08-12-2011

US pharma company Dendreon (Nasdaq: DNDN) says that it has agreed to sell for $125 million in cash its…

Anti-viralsBiotechnologyDendreonFinancialLicensingMerck & CoOncologyPharmaceuticalProvengeVictrelis

Theratechnologies to quit COPD program

08-12-2011

Canada-based Theratechnologies (TSX: TH.TO) revealed yesterday that it is discontinuing its muscle wasting…

EgriftaFinancialNephrology and HepatologyPharmaceuticalResearchRespiratory and PulmonarytesamorelinTheratechnologies

Voraxaze out-licensed in Japan

07-12-2011

UK health care firm BTG (LSE: BGC) says that it has licensed the Japanese rights to glucarpidase (which…

Asia-PacificBTGglucarpidaseLicensingOhara PharmaceuticalOncologyPharmaceuticalVoraxaze

Diabetes Rxing in China and S Korea

07-12-2011

Dipeptidyl peptidase IV (DPP-IV) inhibitors are prescribed more commonly for the treatment of type 2…

Asia-PacificDiabetesGalvusJanuviaMarkets & MarketingMerck & CoNovartisPharmaceuticalPricing

EMA and EFPIA debate modelling

07-12-2011

Modelling and simulation methodology provides an opportunity to improve the efficiency of pharmaceutical…

EuropePharmaceuticalRegulationResearch

China to strengthen drug safety

07-12-2011

China’s State Council (Cabinet) this week approved a blueprint to establish a credit rating system…

Asia-PacificHealthcarePharmaceuticalRegulation

Generic strategic alliances

07-12-2011

The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public…

GenericsMergers & Acquisitions

Biogen Idec forms JV with Korea’s Samsung for biosimilars

07-12-2011

US biotechnology firm Biogen Idec (Nasdaq: BIIB) has entered into an agreement with Korea’s largest…

Biogen IdecSamsung BioLogics

FDA eases REMS requirements for Amgen’s Nplate and GSK’s Promacta

07-12-2011

The US Food and Drug Administration says that an agency initiated review of the current information has…

AmgenBiotechnologyGlaxoSmithKlineNorth AmericaNplatePharmaceuticalPromactaRare diseasesRegulation

More cancer and HIV drugs added to Australian PBS

07-12-2011

More than 160,000 patients will benefit directly from changes to Australia’s Pharmaceutical Benefits…

AmgenAnti-viralsAsia-PacificGilead SciencesOncologyPharmaceuticalPrezistaPricingRegulationXgeva

Merck & Co commits $1.5 billion to R&D in China over next five years

07-12-2011

Adding to the flow of pharmaceutical investment into the BRIC (Brazil, Russia, India and China) countries,…

Asia-PacificFinancialMerck & CoPharmaceuticalResearch

Novartis in licensing deal with Cellectis; pays milestone to GenVec

07-12-2011

Paris, France-based Cellectis genome engineering specialist (Alternext: ALCLS) has signed a license agreement…

BiotechnologyCellectisGenVecLicensingNeurologicalNovartisPharmaceutical

Takeda to establish dedicated vaccine business division

06-12-2011

Japan’s largest drugmaker, Takeda Pharmaceutical (TYO: 4502), says it plans to establish a Vaccine…

ManagementPharmaceuticalResearchTakeda PharmaceuticalsVaccines

New start-up TopiVert gets $12.5 million funding

06-12-2011

UK investment group Imperial Innovations (AIM: IVO) and SV Life Sciences have committed to invest £8…

FinancialInflammatory diseasesJohnson & JohnsonPharmaceuticalResearchRespiVertTopiVert

NSCL cancer drug market set to grow 2.5% a year between 2010 and 2020, despite generic erosion

06-12-2011

Despite the arrival of generic competition – and ensuing sales erosion for several key agents used…

GenericsMarkets & MarketingOncologyPharmaceutical

Unigene regains exclusive worldwide rights of oral PTH analog from GlaxoSmithKline

06-12-2011

USA-based Unigene Laboratories (OTCBB: UGNE) says it has terminated its amended and restated exclusive…

Anti-Arthritics/RheumaticsGlaxoSmithKlineLicensingPharmaceuticalUnigene Labs

UK government boost to life science industry includes early access to news drugs

06-12-2011

A multi million pound package of measures were outlined by the Prime Minister David Cameron to support…

BiotechnologyEuropeFinancialHealthcarePharmaceuticalPoliticsResearch

EU approval for added use of Novartis diabetes drug Galvus

06-12-2011

The European Commission has approved Swiss drug major Novartis’ (NOVN: VX) Galvus (vildagliptin)…

DiabetesEuropeGalvusNovartisPharmaceuticalRegulation

Turkish pharma concerns on drug discounts and pricing

06-12-2011

Turkey’s Association of Research-Based Pharmaceutical Companies (AiFD) has expressed concerns about…

EuropePharmaceuticalPoliticsPricing

Physicians' perception of sales representative calls assessed by Cegedim

05-12-2011

Audited marketing figures on physicians' perception of sales representative calls, showing that 93.8%…

GlobalMarkets & MarketingPharmaceutical

Industry stakeholders deliberate the health care status of India

05-12-2011

To address the burgeoning concern about the need to ensure health care access in India, the Confederation…

Asia-PacificHealthcarePharmaceutical

7878 to 7902 of 8831 results

Back to top